Publikationen Prof. Dr. med. Susanne Beckebaum | Prof. Dr. med. Vito Cicinnati

Beckebaum S, Cicinnati VR, Dworacki G, Müller-Berghaus J, Stolz D, Harnaha J, Whiteside TL, Thomson AW, Lu L, Fung JJ, Bonham CA. Reduction in the circulating pDC1/pDC2 ratio and impaired function of ex vivo-generated DC1 in chronic hepatitis B infection. Clin Immunol 2002;104:138-150.

Beckebaum S, Cicinnati VR, Gerken G. DNA-based immunotherapy: potential for treatment of chronic viral hepatitis? Rev Med Virol 2002;12:297-319.

Beckebaum S, Cicinnati VR, Zhang X, Ferencik S, Frilling A, Grosse-Wilde H, Broelsch CE, Gerken G. Hepatitis B virus-induced defect of monocyte-derived dendritic cells leads to impaired T helper type 1 response in vitro: mechanisms for viral immune escape. Immunology 2003;109:487-495.

Beckebaum S, Cicinnati VR, Karliova M, Dirsch O, Erim Y, Frilling A, Malago M, Broelsch CE, Treichel U, Gerken G. Daily interferon alpha-2B and ribavirin combination therapy for liver transplant patients with chronic hepatitis C infection. Transplant Proc 2003;35:2080-2081.

Beckebaum S, Cicinnati VR, Gerken G, Broelsch CE. Treatment of hepatitis B reinfection after liver transplantation. Minerva Chir 2003; 58: 705-16.

Beckebaum S, Malagó M, Dirsch O, Cicinnati VR, Trippler M, Lampertico P, Lama N, Treichel U, Gerken G, Broelsch CE. Efficacy of combined lamivudine and adefovir dipivoxil treatment for severe HBV graft reinfection after living donor liver transplantation. Clin Transpl 2003;17:554-559.

Beckebaum S, Cicinnati VR, Zhang X, Malago M, Dirsch O, Erim Y, Frilling A, Broelsch CE, Gerken G. Combination therapy with peginterferon alpha-2B and ribavirin in liver transplant recipients with recurrent HCV infection: preliminary results of an open prospective study. Transplant Proc 2004;36:1489-1491.

Breuhahn K, Vreden S, Haddad R, Beckebaum S, Stippel D, Flemming P, Nussbaum T, Caselmann WH, Haab BB, Schirmacher P. Molecular profiling of human hepatocellular carcinoma defines mutually exclusive interferon regulation and insulin-like growth factor II overexpression. Cancer Res 2004;64:6058-6064.

Frilling A, Li J, Weber F, Frühauf NR, Engel J, Beckebaum S, Paul A, Zöpf T, Malago M, Broelsch CE. Major bile duct injuries after laparoscopic cholecystectomy: a tertiary center experience. J Gastrointest Surg 2004;8:679-685.

Beckebaum S, Zhang X, Chen X, Yu Z, Frilling A, Dworacki G, Grosse-Wilde H, Broelsch CE, Gerken G, Cicinnati VR. Increased levels of interleukin-10 in serum from patients with hepatocellular carcinoma correlate with profound numerical deficiencies and immature phenotype of circulating dendritic cell subsets. Clin Cancer Res 2004;10:7260-7269.

Beckebaum S, Cicinnati VR, Klein CG, Brokalaki E, Yu Z, Malago M, Frilling A, Gerken G, Broelsch CE. Impact of combined mycophenolate mofetil and low-dose calcineurin inhibitor therapy on renal function, cardiovascular risk factors, and graft function in liver transplant patients: preliminary results of an open prospective study. Transplant Proc 2004;36:2671-2674

Broelsch CE, Frilling A, Sotiropolous G, Nadalin S, Weber F, Beckebaum S, Malago M. Lebertransplantation und Lebendspende bei Tumoren. Viszeralchirurgie 2004; 39:109-113.

Beckebaum S, Cicinnati VR, Brokalaki E, Klein CG, Malago M, Frilling A, Gerken G, Broelsch CE. CNI sparing regimens within the liver transplant setting: experiences of a single center. Clin Transplants 2004;215-220.

Beckebaum S, Cicinnati V, Broelsch CE. Advances and limitations of liver transplantation in Germany. Verh Dtsch Ges Path 2004;88:45-50.

Beckebaum S, Cicinnati VR, Gerken G, Broelsch CE. Management of chronic hepatitis B in the liver transplant setting. Transplant Rev 2004;18:171-182.

Beckebaum S, Cicinnati VR, Broelsch CE. Future directions in immunosuppression. Transplant Proc 2004; 36(2 Suppl): 574S-576S.

Fruehauf NR, Malago M, Frilling A, Beckebaum S, Broelsch CE. Latest development in split liver transplantation. Surg Technol Int 2004;13:183-189.

Beckebaum S, Bircher J, Gallenkamp H. Bioavailability of ciprofloxacin in patients with acute infectious diarrhoe. Eur J Clin Pharmacol 1996;50:511-512.

Cicinnati VR, Dworacki G, Albers A, Beckebaum S, Tüting T, Kaczmarek E, DeLeo AB. Impact of p53-based immunization on primary chemically-induced tumors. Int J Cancer 2005;113:961-970.

Dworacki G, Cicinnati VR, Beckebaum S, Pizzoferrato E, Hoffmann TK, De Leo AB. Unpulsed dendritic cells induce broadly applicable anti-tumor immunity in mice. Cancer Biol Ther 2005;4:50-56.

Frilling A, Stavrou GA, Mischinger HJ, de Hemptinne B, Rokkjaer M, Klempnauer J, Thörne A, Gloor B, Beckebaum S, Ghaffar MF, Broelsch CE. Effectiveness of a new carrier-bound fibrin sealant versus argon beamer as haemostatic agent during liver resection: a randomised prospective trial. Langenbecks Arch Surg 2005;390:114-120.

Broelsch CE, Frilling A, Bockhorn M, Fruhauf N, Beckebaum S, Paul A, Malago M. Surgical and interventional treatment of liver metastases. MMW Fortschr Med 2005; 147(1-2): 21-24.

Bockhorn M, Frilling A, Nadalin S, Weber F, Beckebaum S, Malago M, Broelsch CE. Neue Techniken in der Lebertransplantation. Schweiz Rundschr Med Prax 2005;94:735-741.

Sotiropoulos GC, Brokalaki EI, Molmenti EP, Beckebaum S, Frilling A, Malagó M, Broelsch CE. Liver transplantation for small solitary cholangiocellular carcinoma in cirrhosis: a medical mistake or a new indication? Transplantation 2005;80:1356.

Sotiropoulos GC, Frilling A, Molmenti EP, Brokalaki EI, Beckebaum S, Omar OS, Broelsch CE, Malago M. De novo hepatocellular carcinoma in recurrent liver cirrhosis after liver transplantation for benign hepatic disease: is a deceased donor re-transplantation justified? Transplantation 2006;82:1112.

Cicinnati VR,Zhang X, Yu Z, Ferencik S, Schmitz KJ, Dworacki G, Kaczmarek E, Oldhafer K, Frilling A, Baba HA, Schmid KW, Grosse-Wilde H, Broelsch CE, DeLeo AB, Gerken G, Beckebaum S. Increased frequencies of CD8+ T lymphocytes recognizing wild-type p53-derived epitopes in peripheral blood correlate with presence of epitope loss tumor variants in patients with hepatocellular carcinoma. Int J Cancer 2006;119:2851-2860.

Malago M, Sotiropoulos GC, Nadalin S, Valentin-Gamazo C, Paul A, Lang H, Radtke A, Saner F, Molmenti E, Beckebaum S, Gerken G, Frilling A, Broelsch CE. Living donor liver transplantation for hepatocellular carcinoma: a single-center preliminary report. Liver Transpl 2006;12:934-940.

Hilgard P, Kahraman A, Lehmann N, Seltmann C, Beckebaum S, Ross RS, Baba HA, Malago M, Broelsch CE, Gerken G. Cyclosporine versus tacrolimus in patients with HCV infection after liver transplantation: effects on virus replication and recurrent hepatitis. World J Gastroenterol 2006;12:697-702.

Frilling A, Malago M, Weber F, Paul A, Nadalin S, Sotiropoulos GC, Cicinnati V, Beckebaum S, Bockisch A, Mueller-Brand J, Hofmann M, Schmid KW, Gerken G, Broelsch CE. Liver transplantation for patients with metastatic endocrine tumors: single-center experience with 15 patients. Liver Transpl 2006;12:1089-1096.

Li J, Dahmen U, Beckebaum S, Cicinnati V, Valentin-Gamazo C, Frilling A, Malago M, Broelsch CE. Target range maximum of cyclosporine blood concentration two hours post dose in stable liver transplant patients. Eur J Med Res 2006;11:139-145.

Sotiropoulos GC, Molmenti EP, Lang H, Beckebaum S, Kaiser GM, Brokalaki EI, Frilling A, Malago M, Neuhauser M, Broelsch CE. Surgery for hepatocellular carcinoma arising in hereditary hemochromatosis. Eur Surg Res 2006;38:371-376.

Erim Y, Beckmann M, Tagay S, Beckebaum S, Gerken G, Broelsch CE, Senf W. Stabilisation of abstinence by means of psychoeducation for patients with alcoholic liver disease awaiting liver transplantation. Z Psychosom Med Psychother 2006;52:341-357.

Erim Y, Möller E, Beckebaum S, Gerken G, Broelsch CE, Senf WE. Manualised group therapy concept for patients with alcoholic cirrhosis awaiting liver transplantation. Z Psychosom Med Psychother 2006;52:243-258.

Beckebaum S, Cicinnati VR, Broelsch CE, Gerken G. Recurrent disease after liver transplantation. A therapeutic dilemma or treatable? Med Klin 2006;101:939-950.

Cicinnati VR, Iacob S, Klein CG, Baba HA, Sotiropoulos GC, Hilgard P, Erim Y, Broelsch CE, Gerken G, Beckebaum S. Ribavirin with either standard or pegylated interferon to treat recurrent hepatitis C after liver transplantation. Aliment Pharmacol Ther 2007;26:291-303.

Iacob S, Cicinnati VR, Hilgard P, Iacob RA, Gheorghe LS, Popescu I, Frilling A, Malago M, Gerken G, Broelsch CE, Beckebaum S. Predictors of graft and patient survival in hepatitis C virus (HCV) recipients: model to predict HCV cirrhosis after liver transplantation. Transplantation 2007;84:56-63.

Cicinnati VR, Yu Z, Klein CG, Sotiropoulos GC, Saner F, Malago M, Frilling A, Gerken G, Broelsch CE, Beckebaum S. Clinical trial: switch to combined mycophenolate mofetil and minimal dose calcineurin inhibitor in stable liver transplant patients -assessment of renal and allograft function, cardiovascular risk factors and immune monitoring. Aliment Pharmacol Ther 2007;26:1195-208.

Sotiropoulos GC, Molmenti EP, Lösch C, Beckebaum S, Broelsch CE, Lang H. Meta-analysis of tumor recurrence after liver transplantation for hepatocellular carcinoma based on 1.198 cases. Eur J Med Res 2007;12:527-34

Cicinnati VR, Kang J, Sotiropoulos GC, Hilgard P, Frilling A, Broelsch CE, Gerken G, Beckebaum S. Altered chemotactic response of myeloid and plasmacytoid dendritic cells from patients with chronic hepatitis C: role of alpha interferon. J Gen Virol 2008;89:1243-1253.

Beckebaum S, Chen X, Sotiropoulos GC, Radtke A, Daoudaki M, Baba HA, Wohlschlaeger J, Broelsch CE, Gerken G, Cicinnati VR. Role of osteopontin and CD44s expression for patients with hepatocellular carcinoma undergoing liver transplantation or resection. Transplant Proc 2008;40:3182-3184.

Cicinnati VR, Shen Q, Sotiropoulos GC, Radtke A, Gerken G, Beckebaum S. Validation of putative reference genes for gene expression studies in human hepatocellular carcinoma using real-time quantitative RT-PCR. BMC Cancer 2008;8:350-361.

Becker T, Foltys D, Bilbao I, D'Amico D, Colledan M, Bernardos A, Beckebaum S, Isoniemi H, Pirenne J, Jaray J; MARSILEA Study Group. Patient outcomes in two steroid-free regimens using tacrolimus monotherapy after daclizumab induction and tacrolimus with mycophenolate mofetil in liver transplantation. Transplantation 2008;86:1689-1694.

Fouzas I, Sotiropoulos GC, Lang H, Nadalin S, Beckebaum S, Sgourakis G, Saner FH, Radtke A, Papanikolaou V, Baba HA, Paul A, Broelsch CE, Malago M. Living donor liver transplantation for hepatocellular carcinoma in patients exceeding the UCSF criteria. Transplant Proc 2008;40:3185-3188.

Radtke A, Sgourakis G, Sotiropoulos GC, Molmenti EP, Fouzas I, Schroeder T, Saner FH, Schenk A, Beckebaum S, Malago M, Lang H. Anatomical classification of the peripheral right hepatic duct: early identification of a preventable source of morbidity and mortality in adult live donor liver transplantation. Transplant Proc 2008;40:3155-157.

Sotiropoulos GC, Kaiser GM, Lang H, Molmenti EP, Beckebaum S, Fouzas I, Sgourakis G, Radtke A, Bockhorn M, Nadalin S, Treckmann J, Niebel W, Baba HA, Broelsch CE, Paul A. Liver transplantation as a primary indication for intrahepatic cholangiocarcinoma: a single-center experience. Transplant Proc 2008;40:3194-3195.

Lang H, Sotiropoulos GC, Beckebaum S, Fouzas I, Molmenti EP, Omar OS, Sgourakis G, Radtke A, Nadalin S, Saner FH, Malago M, Gerken G, Paul A, Broelsch CE. Incidence of liver retransplantation and its effect on patient survival. Transplant Proc 2008;40:3201-3203.

Sotiropoulos GC, Lang H, Saner FH, Beckebaum S, Wandelt M, Molmenti EP, Nadalin S, Treckmann J, Bockhorn M, Fouzas I, Malago M, Gerken G, Broelsch CE, Paul A. Long-term results after liver transplantation with "livers that nobody wants" within Eurotransplant: a center's experience. Transplant Proc 2008;40;3196-3197.

Sotiropoulos GC, Beckebaum S, Lang H, Frilling A, Molmenti EP, Cicinnati VR, Saner FH, Erim Y, Baba HA, Malago M, Broelsch CE. Single-center experience on liver transplantation for hepatocellular carcinoma arising in alcoholic cirrhosis: results and ethical issues. Eur Surg Res 2008;40:7-13.

Sotiropoulos GC, Kuehl H, Sgourakis G, Molmenti EP, Beckebaum S, Cicinnati VR, Baba HA, Schmitz KJ, Broelsch CE, Lang H. Pulmonary nodules at risk in patients undergoing liver transplantation for hepatocellular carcinoma. Transpl Int 2008;21:850-856.

Beckebaum S, Cicinnati VR, Gerken G. Current concepts for prophylaxis and treatment of  hepatitis B reinfection after liver transplantation. Med Klin 2008;103:190-197.

Sotiropoulos GC, Beckebaum S, Molmenti EP, Klein CG, Cicinnati VR, Broelsch CE, Malago M. Multi-organ early tumor dissemination after high urgency re-transplantation for hepatocellular carcinoma in cirrhosis: role of massive intraoperative transfusion? Dig Dis Sci 2008;53:1156-1157.

Sotiropoulos GC, Malago M, Bockhorn M, Schmitz KJ, Radtke A, Molmenti EP, Schaffer R, Beckebaum S, Cicinnati VR, Fouzas I, Broelsch CE, Lang H. Liver transplantation for hepatocellular carcinoma and cirrhosis in candidates with undetectable or very low alpha-fetoprotein levels: is an expansion of the listing criteria justified? Hepatogastroenterology 2008;55:1671-1677.

Sotiropoulos GC, Hilgard P, Antoch G, Nowak KM, Ertl J, Fouzas I, Molmenti EP, Sgourakis G, Beckebaum S, Paul A, Broelsch CE, Lang H. Liver transplantation for hepatocellular carcinoma after yttrium therapy: a case report. Transplant Proc 2008;40:3804-3805.

Fouzas I, Sotiropoulos GC, Molmenti EP, Beckebaum S, Schmitz KJ, Broelsch CE, Lang H, Malago M. "Preemptive" live donor liver transplantation for fibrolamellar hepatocellular carcinoma: a case report. Transplant Proc 2008;40:3806-3807

Iacob S, Cicinnati V, Beckebaum S. Current immunosuppressive approaches in liver transplantation. Panminerva Med 2009;51:215-25.

Cicinnati V, Beckebaum S, Gerken G. Lebertransplantationen bei autoimmunen Lebererkrankungen. Der Gastroenterologe 2009;4:124-129.

Beckebaum S, Sotiropoulos GC, Gerken G, Cicinnati VR. Hepatitis B and liver transplantation: 2008 update. Rev Med Virol 2009;19:7-29 (IF 7,449)

Cicinnati VR, Kang J, Hou J, Lindemann M, Koop K, Tüting T, Gerken G, Beckebaum S. Interferon-alpha differentially affects homeostasis of human plasmacytoid and myeloid dendritic cells. J Interferon Cytokine Res 2009;29(3):145-160.

Beckebaum S, Sotiropoulos GC, Klein CG, Broelsch CE, Saner F, Paul A, Gerken G, Cicinnati VR. Predictive factors of outcome in patients transplanted for hepatitis B. Transplantation 2009;87:872-881.

Beckebaum S, Armstrong VW, Cicinnati VR, Streit F, Klein CG, Gerken G, Paul A, Oellerich M. Pharmacokinetics of mycophenolic acid and its glucuronide metabolites in stable adult liver transplant recipients with renal dysfunction on a low-dose calcineurin inhibitor regimen and mycophenolate mofetil. Ther Drug Monit 2009;31:205-210.

Beckebaum S, Klein C, Varghese J, Sotiropoulos GC, Saner F, Schmitz K, Gerken G, Paul A, Cicinnati VR. Renal function and cardiovascular risk profile after conversion from ciclosporin to tacrolimus: prospective study in 80 liver transplant recipients. Aliment Pharmacol Ther 2009;30:834-842.

Cicinnati VR, Hou J, Lindemann M, Horn PA, Sotiropoulos GC, Paul A, Gerken G, Beckebaum S. Mycophenolic acid impedes the antigen presenting and lymph node homing capacities of human blood myeloid dendritic cells. Transplantation 2009;88:504-513.

Beckebaum S, Klein CG, Sotiropoulos GC, Saner FH, Gerken G, Paul A, Cicinnati VR. Combined mycophenolate mofetil and minimal dose calcineurin inhibitor therapy in liver transplant patients: clinical results of a prospective randomized study. Transplant Proc 2009;41: 2567-2569.

Sotiropoulos GC, Lang H, Sgourakis G, Nadalin S, Molmenti EP, Radtke A, Paul A, Beckebaum S, Saner FH, Baba HA, Gerken G, Malago M, Broelsch CE. Liberal policy in living donor liver transplantation for hepatocellular carcinoma: lessons learned. Dig Dis Sci 2009;54:377-384.

Sotiropoulos GC, Drühe N, Sgourakis G, Molmenti EP, Beckebaum S, Baba HA, Antoch G, Hilgard P, Radtke A, Saner FH, Nadalin S, Paul A, Malago M, Broelsch CE, Lang H. Liver transplantation, liver resection, and transarterial chemoembolization for hepatocellular carcinoma in cirrhosis: which is the best oncological approach? Dig Dis Sci 2009;54:2264-2273.

Baba HA, Wohlschlaeger J, Cicinnati VR, Hilgard P, Lang H, Sotiropoulos GC, Takeda A, Beckebaum S, Schmitz KJ. Phosphorylation of p70S6 kinase predicts overall survival in patients with clear margin-resected hepatocellular carcinoma. Liver Int 2009;29:399-405.

Lindemann M, Dioury Y, Beckebaum S, Cicinnati VR, Gerken G, Broelsch CE, Wrighton-Smith P, Grosse-Wilde H. Diagnosis of tuberculosis infection in patients awaiting liver transplantation. Hum Immunol 2009;70:24-28.

Saner FH, Heuer M, Meyer M, Canbay A, Sotiropoulos GC, Radtke A, Treckmann J, Beckebaum S, Dohna-Schwake C, Oldedamink SW, Paul A. When the heart kills the liver: acute liver failure in congestive heart failure. Eur J Med Res 2009;14:541-546.

Beckebaum S, Iacob S, Klein CG, Dechene A, Varghese J, Baba HA, Sotiropoulos G, Paul A, Gerken G, Cicinnati VR. Assessment of allograft fibrosis by transient elastography and non-invasive biomarker scoring systems in liver transplant patients. Transplantation 2010;89:983-993.

Shen Q, Cicinnati VR, Zhang X, Iacob S, Weber F, Sotiropoulos GC, Radtke A, Lu M, Paul A, Gerken G, Beckebaum S. Role of microRNA-199a-5p and discoidin domain receptor 1 in human hepatocellular carcinoma invasion. Mol Cancer 2010;9:227-239.

Saner FH, Damink SW, Pavlaković G, Sotiropoulos GC, Radtke A, Treckmann J, Beckebaum S, Cicinnati V, Paul A. Is positive end-expiratory pressure suitable for liver recipients with a rescue organ offer? J Crit Care 2010;25(3):477-482.

Saner FH, Gensicke J, Olde Damink SW, Pavlaković G, Treckmann J, Dammann M, Kaiser GM, Sotiropoulos GC, Radtke A, Koeppen S, Beckebaum S, Cicinnati V, Nadalin S, Malago M, Paul A, Broelsch CE. Neurologic complications in adult living donor liver transplant patients: an underestimated factor? J Neurol 2010;257:253-258.

Erim Y, Tagay S, Beckmann M, Bein S, Cicinnati V, Beckebaum S, Senf W, Schlaak JF. Depression and protective factors of mental health in people with hepatitis C: a questionnaire survey. Int J Nurs Stud 2010;47:342-349.

Radtke A, Sgourakis G, Sotiropoulos GC, Beckebaum S, Molmenti EP, Saner FH, Schroeder T, Nadalin S, Schenk A, Lang H, Malago M, Broelsch CE. Donor/recipient algorithm for management of the middle hepatic vein in right graft live donor liver transplantation. Am J Surg 2010;199(5):708-715.

Sotiropoulos GC, Miyazaki M, Konstadoulakis MM, Paul A, Molmenti EP, Gomatos IP, Radtke A, Baba HA, Beckebaum S, Brokalaki EI, Ohtsuka M, Schwartz ME, Broelsch CE, Sgourakis G. Multicentric evaluation of a clinical and prognostic scoring system predictive of survival after resection of intrahepatic cholangiocarcinomas. Liver Int 2010;30(7):996-1002.

Kocabayoglu P, Treckmann JW, Beckebaum S, Sotiropoulos GC, Radtke A, Paul A, Saner FH. Does long-term ventilation with PEEP > or = 10mbar influence graft-function in patients following liver transplantation? Hepatogastroenterology 2010;57(101): 839-844

Saner FH, Olde Damink SW, Pavlaković G, Sotiropoulos GC, Radtke A, Treckmann J, Beckebaum S, Cicinnati V, Paul A. How far can we go with positive end-expiratory pressure (PEEP) in liver transplant patients? J Clin Anesth 2010; 22:104-109.

Radtke A, Sotiropoulos GC, Sgourakis G, Molmenti EP, Schroeder T, Saner FH, Beckebaum S, Broelsch CE, Broering DC, Malago M. Hepatic venous Drainage: How much can we learn from imaging studies? Anatomical-functional classification derived from 3-Dimensional CT reconstructions. Transplantation 2010;89(12):1518-25.

Schnitzbauer AA, Zuelke C, Graeb C, Rochon J, Bilbao I, Burra P, de Jong KP, Duvoux C, Kneteman NM, Adam R, Bechstein WO, Becker T, Beckebaum S, Chazouillères O, Cillo U, Colledan M, Fändrich F, Gugenheim J, Hauss JP, Heise M, Hidalgo E, Jamieson N, Königsrainer A, Lamby PE, Lerut JP, Mäkisalo H, Margreiter R, Mazzaferro V, Mutzbauer I, Otto G, Pageaux GP, Pinna AD, Pirenne J, Rizell M, Rossi G, Rostaing L, Roy A, Turrion VS, Schmidt J, Troisi RI, van Hoek B, Valente U, Wolf P, Wolters H, Mirza DF, Scholz T, Steininger R, Soderdahl G, Strasser SI, Jauch KW, Neuhaus P, Schlitt HJ, Geissler EK. A prospective, randomized, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma. BMC Cancer 2010;10:190-197.

Kaiser G, Sotiropoulos GC, Sgourakis G, Bleck J, Baba H, Beckebaum S, Gerken G, Paul A. Surgical treatment of Klatskin tumor: Liver resection versus transplantation. Hepatogastroenterology 2010; 57(104):1337-40.

Kaiser GM, Sotiropoulos GC, Sgourakis G, Bleck J, Baba HA, Beckebaum S, Gerken G, Paul A, Trarbach T. Surgical treatment of Klatskin tumor: liver resection versus transplantation. Hepatogastroenterology 2010;57(104):1337-1340.

Erim Y, Beckmann M, Gerken G, Paul A, Senf W, Beckebaum S. Psychosomatic aspects of living donor liver transplantation. Der Chirurg 2010;81:820-825.

Erim Y, Beckmann M, Beckebaum S, CG Klein, Paul A, Senf W. Patients with alcohol related disorders in the frame of liver transplantation. Ärztliche Psychotherapie 2010; 53:156-161.

Saner FH, Plicht B, Treckmann J, Mathe Z, Sotiropoulos GC, Radtke A, Beckebaum S, Cicinnati V, Paul A. Tako-Tsubo syndrome as a rare cause of cardiac failure in liver transplantation. Liver Int 2010;30:159-160.

Sotiropoulos GC, Malago M, Molmenti EP, Radtke A, Fouzas I, Beckebaum S, Saner FH, Paul A, Lang H, Broelsch CE. Impact of a living donor liver transplant program for hepatocellular carcinoma to the running local deceased donor liver transplant program. Dig Dis Sci 2010;55:872-873.

Vernadakis S, Mathe Z, Kaiser GM, Treckmann JW, Beckebaum S, Paul A, Sotiropoulos GC. Liver transplantation in cirrhotic patients with hepatocellular carcinoma and concomitant HIV infection: two more reasons to accept or to deny? Transplantation 2010; 90(1): 97-98.

Beckebaum S, Cicinnati VR. Conversion to combined mycophenolate mofetil and low dose calcineurin inhibitor therapy for renal dysfunction in liver transplant patients: never too late? Dig Dis Sci 2010;56(1):4-6

Cicinnati V, Sotiropoulos GC, Beckebaum S. Established and emerging therapies for hepatocellular carcinoma. Minerva Med 2010;101(6):405-418.

Vernadakis S, Cicinnati VR, Beckebaum S, Paul A, Sotiropoulos GC. Colorectal cancer following liver transplantation. Int J Colorectal Dis 2011 Mar 10.

Saner F, Cicinnati VR, Sotiropoulos G, Beckebaum S. Strategies to prevent or reduce acute and chronic kidney injury in liver transplantation. Liver Int 2011; doi: 10.1111/j.1478-3231.2011.02563.x

Weismüller TJ, Fikatas P, Schmidt J, Barreiros AP, Otto G, Beckebaum S, Paul A, Scherer MN, Schmidt HH, Schlitt HJ, Neuhaus P, Klempnauer J, Pratschke J, Manns MP, Strassburg CP. Multicentric evaluation of model for end-stage liver disease-based allocation and survival after liver transplantation in Germany - limitations of the 'sickest first'-concept. Transpl Int 2011;24(1):91-99.

Máthé Z, Paul A, Tagkalos E, Molmenti EP, Kobori L, Fouzas I, Beckebaum S, Sotiropoulos GC. Liver transplantation for hepatic metastases of neuroendocrine pancreatic tumors: A survival based analysis. Transplantation 2011;15:91(5):575-582.

Radtke A, Sotiropoulos GC, Sgourakis G, Molmenti EP, Schroeder T, Saner FH, Beckebaum S, Schenk A, Lang H, Broelsch CE, Malago M. "Anatomical" versus "territorial" belonging of the middle hepatic vein: Virtual imaging and clinical repercussions. J Surg Res 2011;166(1):146-155.

Pei R, Chen H, Lu L, Zhu W, Beckebaum S, Cicinnati V, Lu M, Chen X. Hepatitis C virus infection induces the expression of amphiregulin, a factor related to the activation of cellular survival pathways and required for efficient viral assembly. J Gen Virol 2011.

Máthé Z, Paul A, Molmenti EP, Vernadakis S, Klein CG, Beckebaum S, Treckmann JW, Cicinnati VR, Kóbori L, Sotiropoulos GC. Liver transplantation with donors over the expected lifespan in the model for end-staged liver disease era: is Mother Nature punishing us? Liver Int 2011;31(7):1054-61.

Yahyazadeh A, Beckebaum S, Cicinnati V, Klein C, Paul A, Pascher A, Neuhaus R. Efficacy and safety of subcutaneous human HBV-immunoglobulin (Zutectra) in liver transplantation: an open, prospective, single-arm phase III study. Transpl Int 2011;24(5):441-50.

Saner FH, Neumann T, Canbay A, Treckmann JW, Hartmann M, Goerlinger K, Bertram S, Beckebaum S, Cicinnati V, Paul A. High brain-natriuretic peptide level predicts cirrhotic cardiomyopathy in liver transplant patients. Transpl Int 2011;24(5):425-32.

Lindemann M, Saure C, Klinkenbusch H, Valentin-Gamazo C, Horn PA, Cicinnati VR, Beckebaum S, Witzke O. Alloreactivity in recipients prior to and post living kidney and liver transplantation. Scand J Immunol 2011;73(4):344-345.

Vernadakis S, Sotiropoulos GC, Brokalaki EI, Esser S, Kaiser GM, Cicinnati VR, Beckebaum S, Paul A, Mathé Z. Long-term outcomes of liver transplant patients with human immunodeficiency virus infection and end-stage-liver-disease: single center experience. Eur J Med Res 2011;16(8):342-8

Beckebaum S, Iacob S, Sweid D, Sotiropoulos GC, Saner F, Kaiser G, Radtke A, Klein CG, Erim Y, de Geest S, Paul A, Gerken G, Cicinnati VR. Efficacy, safety, and immunosuppressant adherence in stable liver transplant patients converted from a twice-daily tacrolimus-based regimen to once-daily tacrolimus extended-release formulation. Transpl Int 2011;24(7):666-675.

Brokalaki EI, Weber F, Sotiropoulos GC, Daoudaki M, Cicinnati VR, Beckebaum S. Claudin-7 expression in hepatocellular carcinoma. Transplant Proc. 2012;44:2737-40

Iacob S, Cicinnati VR, Dechêne A, Lindemann M, Heinemann FM, Rebmann V, Ferencik S, Sotiropoulos GC, Popescu I, Horn PA, Gerken G, Paul A, Beckebaum S. Genetic, immunological and clinical risk factors for biliary strictures following liver transplantation. Liver Int. 2012. doi: 10.1111/j.1478-3231.2012.02810.x.

Kabar I, Cicinnati VR, Beckebaum S, Cordesmeyer S, Reinecke H, Schmidt HH. Introducing Paclitaxel-eluting balloons as a new treatment option of biliary-enteric anastomotic stricture after liver transplantation. Transplantation. 2012;94:e4-5.

Radtke A, Sotiropoulos GC, Molmenti EP, Sgourakis G, Schroeder T, Beckebaum S, Peitgen HO, Cicinnati VR, Broelsch CE, Broering DC, Malagó M. Transhilar passage in right graft live donor liver transplantation: intrahilar anatomy and its impact on operative strategy. Am J Transplant. 2012;12:718-27. doi: 10.1111/j.1600-6143.2011.03827.x.

Kabar I, Cicinnati VR, Beckebaum S, Cordesmeyer S, Avsar Y, Reinecke H, Schmidt HH. Use of paclitaxel-eluting balloons for endotherapy of anastomotic strictures following liver transplantation. Endoscopy. 2012;44:1158-60.

Radtke A, Sgourakis G, Molmenti EP, Beckebaum S, Cicinnati V, Broelsch CE, Peitgen HO, Malagó M, Schroeder T. Computer-Assisted Surgical Planning in Adult-to-Adult Live Donor Liver Transplantation: How Much Does it Help? A Single Center Experience. Transplantation. 2012;94:1138-1144.

Cicinnati VR, Beckebaum S, Schmidt HH. Lebertransplantation – Indikationsstellung, Vor- und Nachsorge. Gastroenterologie up2date 2012; 8:25-43.

Beckebaum S, Kabar I, Cicinnati VR. Hepatitis B and C in liver transplantation: new strategies to combat the enemies. Rev Med Virol 2012. doi: 10.1002/rmv.1734

Beckebaum S, Cicinnati VR, Radtke A, Kabar I. Calcineurin inhibitors in liver transplantation - still champions or threatened by serious competitors? Liver Int 2013; doi: 10.1111/liv.12133

Beckebaum S, lacob S, Radtke A, Kabar I, Cicinnati VR. Body weight may not be sufficient for reliable estimation of subcutaneous hepatitis B immunoglobulin dose requirement. Am J Transplant. 2013. doi: 10.1002/ajt.12247

Radtke A, Sgourakis G, Molmenti EP, Schroeder T, Cicinnati VR, Beckebaum S, Peitgen HO, Broelsch CE, Malagó M. The "carving" liver partitioning technique for graft hepatectomy in live donor liver transplantation: A single-center experience. Surgery. 2013;153:189-99.

Klein CG, Cicinnati V, Schmidt H, Ganten T, Scherer MN, Braun F, Zeuzem S, Wartenberg-Demand A, Niemann G, Schmeidl R, Beckebaum S. Compliance and tolerability of subcutaneous hepatitis B immunoglobulin self-administration in liver transplant patients: a prospective, observational, multicenter study. Ann Transplant. 2013;18:677-84. doi: 10.12659/AOT.889269.

Xu L, Beckebaum S, Iacob S, Wu G, Kaiser GM, Radtke A, Liu C, Kabar I, Schmidt HH, Zhang X, Lu M, Cicinnati VR. MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity. J Hepatol. 2014 Mar;60(3):590-8. doi: 10.1016/j.jhep.2013.10.028.

Erim Y, Beckmann M, Klein C, Paul A, Beckebaum S. Psychother Psychosom Med Psychol. 2013 Jun;63(6):238-46; 247-9. doi: 10.1055/s-0033-1343191.

Saliba F, De Simone P, Nevens F, De Carlis L, Metselaar HJ, Beckebaum S, Jonas S, Sudan D, Fischer L, Duvoux C, Chavin KD, Koneru B, Huang MA, Chapman WC, Foltys D, Dong G, Lopez PM, Fung J, Junge G; H2304 Study Group. Renal function at two years in liver transplant patients receiving everolimus: results of a randomized, multicenter study. Am J Transplant. 2013 Jul;13(7):1734-45. doi: 10.1111/ajt.12280.

Beckebaum S, Iacob S, Radtke A, Kabar I, Cicinnati VR. Body weight may not be sufficient for reliable estimation of subcutaneous hepatitis B immunoglobulin dose requirement. Am J Transplant. 2013 Jun;13(6):1615-6. doi: 10.1111/ajt.12247. 

De Simone P, Beckebaum S, Koneru B, Fung J, Saliba F. Everolimus with reduced tacrolimus in liver transplantation. Am J Transplant. 2013 May;13(5):1373-4. doi: 10.1111/ajt.12215.

Beckebaum S, Cicinnati VR, Radtke A, Kabar I. Calcineurin inhibitors in liver transplantation - still champions or threatened by serious competitors? Liver Int. 2013 May;33(5):656-65. doi: 10.1111/liv.12133.

Schlitt HJ, Jonas S, Ganten TM, Grannas G, Moench C, Rauchfuss F, Obed A, Tisone G, Pinna AD, Gerunda GE, Beckebaum S. Effects of mycophenolate mofetil introduction in liver transplant patients: results from an observational, non-interventional, multicenter study (LOBSTER). Clin Transplant. 2013 May-Jun;27(3):368-78. doi: 10.1111/ctr.12097.

Beckebaum SK, Schmidt HH. Begin of a new era in treating hepatitis C in Patients on the waiting list and after liver transplantation. Z Gastroenterol. 2014 Jul;52(7):746-8. doi: 10.1055/s-0034-1366287.

Pillukat MH, Bester C, Hensel A, Lechtenberg M, Petereit F, Beckebaum S, Müller KM, Schmidt HH. Concentrated green tea extract induces severe acute hepatitis in a 63-year-old woman--a case report with pharmaceutical analysis. J Ethnopharmacol. 2014 Aug 8;155(1):165-70. doi: 10.1016/j.jep.2014.05.015.

Avsar Y, Cicinnati VR, Kabar I, Wolters H, Anthoni C, Schmidt HH, Beckebaum S. Small bowel transplantation complicated by cytomegalovirus tissue invasive disease without viremia. J Clin Virol. 2014 Jun;60(2):177-80. doi: 10.1016/j.jcv.2014.03.005.

Allkemper T, Sagmeister F, Cicinnati V, Beckebaum S, Kooijman H, Kanthak C, Stehling C, Heindel W. Evaluation of fibrotic liver disease with whole-liver T1ρ MR imaging: a feasibility study at 1.5 T. Radiology. 2014 May;271(2):408-15. doi: 10.1148/radiol.13130342.

Iacob S, Cicinnati VR, Lindemann M, Heinemann FM, Radtke A, Kaiser GM, Kabar I, Schmidt HH, Baba HA, Beckebaum S. Donor-Specific Anti-HLA Antibodies and Endothelial C4d Deposition-Association With Chronic Liver Allograft Failure. Transplantation. 2015 Sep;99(9):1869-75. doi: 10.1097/TP.0000000000000613.

Hüsing A, Reinecke H, Cicinnati VR, Beckebaum S, Wilms C, Schmidt HH, Kabar I. Paclitaxel-eluting balloon dilation of biliary anastomotic stricture after liver transplantation. World J Gastroenterol. 2015 Jan 21;21(3):977-81. doi: 10.3748/wjg.v21.i3.977.

Hüsing A, Cicinnati VR, Beckebaum S, Wilms C, Schmidt HH, Kabar I. Endoscopic ultrasound: valuable tool for diagnosis of biliary complications in liver transplant recipients? Surg Endosc. 2015 Jun;29(6):1433-8. doi: 10.1007/s00464-014-3820-3.

Best J, Zahn A, Beilfuß A, Sydor S, Fingas C, Sowa JP, Anastasiou O, Cicinnati V, Gerken G, Canbay A, Bechmann LP. Mycophenolic acid induces apoptosis of hepatic stellate cells in an in vitro model of HCV. Ann Hepatol. 2015 May-Jun;14(3):396-403.

Schumann A, Fiedler M, Beckebaum S, Cicinnati VR, Herzer K, Lenz V, Witzke O, Paul A, Roggendorf M, Horn PA, Lindemann M. Donor- and recipient-derived immunity in ABO incompatible living-related liver transplantation. Hum Immunol. 2015 Sep;76(9):631-5. doi: 10.1016/j.humimm.2015.09.008.

Seifert LL, Vorona E, Bester C, Stahl M, Hüsing A, Beckebaum S, Kabar I, Heinzow H, Schmidt HH. Interferon-Free Sofosbuvir-Based Anti-HCV Therapy After Liver Transplantation. Ann Transplant. 2015 Sep 22;20:561-8. doi: 10.12659/AOT.893640.

Hüsing A, Cicinnati VR, Maschmeier M, Schmidt HH, Wolters HH, Beckebaum S, Kabar I. Complications after endoscopic sphincterotomy in liver transplant recipients: A retrospective single-centre study. Arab J Gastroenterol. 2015 Jun;16(2):46-9. doi: 10.1016/j.ajg.2015.04.001.

Erim Y, Böttcher M, Schieber K, Lindner M, Klein C, Paul A, Beckebaum S, Mayr A, Helander A. Feasibility and Acceptability of an Alcohol Addiction Therapy Integrated in a Transplant Center for Patients Awaiting Liver Transplantation. Alcohol Alcohol. 2016 Jan;51(1):40-6. doi: 10.1093/alcalc/agv075.

Radtke A, Sgourakis G, Molmenti EP, Beckebaum S, Cicinnati VR, Schmidt H, Peitgen HO, Broelsch CE, Malagó M, Schroeder T. Risk of venous congestion in live donors of extended right liver graft. World J Gastroenterol. 2015 May 21;21(19):6008-17. doi: 10.3748/wjg.v21.i19.6008.

Kabar I, Hüsing A, Cicinnati VR, Heitschmidt L, Beckebaum S, Thölking G, Schmidt HH, Karch H, Kipp F. Analysis of bile colonization and intestinal flora may improve management in liver transplant recipients undergoing ERCP. Ann Transplant. 2015 May 4;20:249-55. doi: 10.12659/AOT.893549.

Pai M, Habib N, Senturk H, Lakhtakia S, Reddy N, Cicinnati VR, Kaba I, Beckebaum S, Drymousis P, Kahaleh M, Brugge W Endoscopic ultrasound guided radiofrequency ablation, for pancreatic cystic neoplasms and neuroendocrine tumors. World J Gastrointest Surg. 2015 Apr 27;7(4):52-9. doi: 10.4240/wjgs.v7.i4.52.

Hüsing A, Schmidt M, Beckebaum S, Cicinnati VR, Koch R, Thölking G, Stella J, Heinzow H, Schmidt HH, Kabar I. Long-Term Renal Function in Liver Transplant Recipients After Conversion From Calcineurin Inhibitors to mTOR Inhibitors. Ann Transplant. 2015 Nov 26;20:707-13.

Agüero F, Rimola A, Stock P, Grossi P, Rockstroh JK, Agarwal K, Garzoni C, Barcan LA, Maltez F, Manzardo C, Mari M, Ragni MV, Anadol E, Di Benedetto F, Nishida S, Gastaca M, Miró JM; FIPSE/NIH HIVTR/NEAT023 Investigators. Liver Retransplantation in Patients With HIV-1 Infection: An International Multicenter Cohort Study. Am J Transplant. 2016 Feb;16(2):679-87. doi: 10.1111/ajt.13461.

Hoyer DP, Kaiser GM, Cicinnati V, Radunz S, Braun F, Greif-Higer G, Schulze M, Schmidt HJ, Paul A, Beckebaum S. Training, work, and lifestyle of transplant physicians and surgeons in Germany. Clin Transplant. 2016 Sep;30(9):1046-52. doi: 10.1111/ctr.12786.

Geissler EK, Schnitzbauer AA, Zülke C, Lamby PE, Proneth A, Duvoux C, Burra P, Jauch KW, Rentsch M, Ganten TM, Schmidt J, Settmacher U, Heise M, Rossi G, Cillo U, Kneteman N, Adam R, van Hoek B, Bachellier P, Wolf P, Rostaing L, Bechstein WO, Rizell M, Powell J, Hidalgo E, Gugenheim J, Wolters H, Brockmann J, Roy A, Mutzbauer I, Schlitt A, Beckebaum S, Graeb C, Nadalin S, Valente U, Turrión VS, Jamieson N, Scholz T, Colledan M, Fändrich F, Becker T, Söderdahl G, Chazouillères O, Mäkisalo H, Pageaux GP, Steininger R, Soliman T, de Jong KP, Pirenne J, Margreiter R, Pratschke J, Pinna AD, Hauss J, Schreiber S, Strasser S, Klempnauer J, Troisi RI, Bhoori S, Lerut J, Bilbao I, Klein CG, Königsrainer A, Mirza DF, Otto G, Mazzaferro V, Neuhaus P, Schlitt HJ. Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial. Transplantation. 2016 Jan;100(1):116-25. doi: 10.1097/TP.0000000000000965.

Thölking G, Siats L, Fortmann C, Koch R, Hüsing A, Cicinnati VR, Gerth HU, Wolters HH, Anthoni C, Pavenstädt H, Suwelack B, Schmidt HH, Kabar I. Tacrolimus Concentration/Dose Ratio is Associated with Renal Function After Liver Transplantation. Ann Transplant. 2016 Mar 22;21:167-79.

Lindner K, Anthoni C, Beckebaum S, Senninger N, Hölzen JP, Wolters H. Cytomegalovirus Treatment Strategy After a Liver Transplant: Preemptive Therapy or Prophylaxis for Cytomegalovirus Seropositive Donor and Recipient. Exp Clin Transplant. 2016 Aug;14(4):419-23.

Zimmermann T, Beckebaum S, Berg C, Berg T, Braun F, Eurich D, Herzer K, Neumann U, Rupp C, Sterneck M, Strassburg C, Welker MW, Zachoval R, Gotthardt DN, Weigand K, Schmidt H, Wedemeyer H, Galle PR, Zeuzem S, Sarrazin C. [Expert recommendations: Hepatitis C and transplantation]. Z Gastroenterol. 2016 Jul;54(7):665-84. doi: 10.1055/s-0042-107360.

Deutsche Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) (federführend); Deutsche Gesellschaft für Innere Medizin (DGIM); Deutsche M. Crohn/Colitis ulcerosa Vereinigung (DCCV); Deutsche Leberhilfe e.V; Deutsche Gesellschaft für Ultraschall in der Medizin (DEGUM); Deutsche Gesellschaft für Endoskopie und Bildgebende Verfahren (DGE-BV); Deutsche Gesellschaft für Kinder- und Jugendmedizin (DGKJ); Gesellschaft für Pädiatrische Gastroenterologie (GPGE); Deutsche Gesellschaft für Rheumatologie (DGRh); Deutsche Röntgengesellschaft (DRG); Deutsche Transplantationsgesellschaft (DTG); Deutsche Gesellschaft für Pathologie (DGP) und Bundesverband Deutscher Pathologen (BDP); Österreichische Gesellschaft für Gastroenterologie (ÖGG); Schweizer Gastroenterologische Gesellschaft (SGG); Authors; Collaborators. [Practice guideline autoimmune liver diseases - AWMF-Reg. No. 021-27]. Z Gastroenterol. 2017 Nov;55(11):1135-1226. doi: 10.1055/s-0043-120199.

Dogan N, Hüsing-Kabar A, Schmidt HH, Cicinnati VR, Beckebaum S, Kabar I. Acute allograft rejection in liver transplant recipients: Incidence, risk factors, treatment success, and impact on graft failure. J Int Med Res. 2018 Sep;46(9):3979-3990. doi: 10.1177/0300060518785543.

Huesing-Kabar A, Dohna CZ, Heinzow H, Cicinnati VR, Beckebaum S, Schmidt M, Gerth HU, Pohlen M, Wilms C, Palmes D, Schmidt HH, Kabar I. Risk factors for allograft failure in liver transplant recipients. Z Gastroenterol. 2018 Jul;56(7):745-751. doi: 10.1055/s-0043-125225.

Behrens A, Kreuzmayr A, Manner H, Koop H, Lorenz A, Schaefer C, Plauth M, Jetschmann JU, von Tirpitz C, Ewald M, Sackmann M, Renner W, Krüger M, Schwab D, Hoffmann W, Engelke O, Pech O, Kullmann F, Pampuch S, Lenfers B, Weickert U, Schilling D, Boehm S, Beckebaum S, Cicinnati V, Erckenbrecht JF, Dumoulin FL, Benz C, Rabenstein T, Haltern G, Balsliemke M, de Mas C, Kleber G, Pehl C, Vogt C, Kiesslich R, Fischbach W, Koop I, Kuehne J, Breidert M, Sass NL, May A, Friedrich C, Veitt R, Porschen R, Ellrichmann M, Arlt A, Schmitt W, Dollhopf M, Schmidbaur W, Dignass A, Schmitz V, Labenz J, Kaiser G, Krannich A, Barteska N, Ell C. Acute sedation-associated complications in GI endoscopy (ProSed 2 Study): results from the prospective multicentre electronic registry of sedation-associated complications. Gut. 2018 Jan 3. pii: gutjnl-2015-311037. doi: 10.1136/gutjnl-2015-311037.

 Paslakis G, Beckmann M, Beckebaum S, Klein C, Gräf J, Erim Y. Posttraumatic Stress Disorder, Quality of Life, and the Subjective Experience in Liver Transplant Recipients. Prog Transplant. 2018 Mar;28(1):70-76. doi: 10.1177/1526924817746680.

Dietz J, Susser S, Vermehren J, Peiffer KH, Grammatikos G, Berger A, Ferenci P, Buti M, Müllhaupt B, Hunyady B, Hinrichsen H, Mauss S, Petersen J, Buggisch P, Felten G, Hüppe D, Knecht G, Lutz T, Schott E, Berg C, Spengler U, von Hahn T, Berg T, Zeuzem S, Sarrazin C; European HCV Resistance Study Group. Patterns of Resistance-Associated Substitutions in Patients With Chronic HCV Infection Following Treatment With Direct-Acting Antivirals. Gastroenterology. 2018 Mar;154(4):976-988.e4. doi: 10.1053/j.gastro.2017.11.007.

Beckebaum S, Herzer K, Bauhofer A, Gelson W, De Simone P, de Man R, Engelmann C, Müllhaupt B, Vionnet J, Salizzoni M, Volpes R, Ercolani G, De Carlis L, Angeli P, Burra P, Dufour JF, Rossi M, Cillo U, Neumann U, Fischer L, Niemann G, Toti L, Tisone G. Recurrence of Hepatitis B Infection in Liver Transplant Patients Receiving Long-Term Hepatitis B Immunoglobulin Prophylaxis. Ann Transplant. 2018 Nov 13;23:789-801. doi: 10.12659/AOT.910176.

Buchkapitel

Cicinnati VR, Beckebaum S, DeLeo AB. Mouse models in the recognition of tumor antigens. In: Tumor Immunology Series III: Tumor antigens recognized by T cells and antibodies. Eds. Stauss HJ, Kawakami Y, Parmiani G. Harwood Academic Publishers 2003.

Beckebaum S, Cicinnati V, Broelsch CE. Liver transplantation, rejection and disease recurrence. In: Cholestatic Liver Diseases: Therapeutical Options and Perspectives. Eds. Leuschner U, Bromé U, Stiehl A. Kluwer Academic Publishers 2004: 55-56.

Cicinnati V, Beckebaum S. Liver transplantation: outcome of liver transplantation in special category of patients (Chapter 46). In: Liver and biliary tract surgery. Eds. Karaliotas CC, Broelsch CE, Habib NA. Springer, Wien/New York 2006: 577-578.

Cicinnati V, Beckebaum S, Frilling A. Disorders of the biliary tract. In: Emergency Surgery. Eds. Fluture V, Frilling A. Editura de Vest, Timisora 2006, 306-352.

Beckebaum S, Cicinnati VR, Frilling A. Acute liver failure - liver transplantation. In: Emergency Surgery. Eds. Fluture V, Frilling A. Editura de Vest, Timisora 2006, 290-305.

Lendemans S, Cicinnati VR, Beckebaum S, Frilling A. Emergencies in liver surgery and liver transplantation: liver trauma. In: Emergency Surgery. Eds. Fluture V, Frilling A. Editura de Vest, Timisora 2006, 279-289.

Sotiropoulos G, Beckebaum S, Gerken G. Recurrent diseases after liver transplantation (Chapter 45c). In: Liver and Biliary Tract Surgery. Eds. Karaliotas CC, Broelsch CE, Habib NA. Springer, Wien/New York 2006: 568-575.

Beckebaum S, Cicinnati V, Frilling A, Gerken G. Long-term complications after liver transplantation (Chapter 45b) In: Liver and Biliary Tract Surgery. Eds. Karaliotas CC, Broelsch CE, Habib NA. Springer Wien/New York 2006: 562-567.

Beckebaum S, Cicinnati V, Frilling A. Pretransplantation management issues (Chapter 41d). In: Liver and Biliary Tract Surgery. Eds. Karaliotas CC, Broelsch CE, Habib NA. Springer Wien/New York 2006: 534-535.

Beckebaum S, Lang H, Frilling A, Gerken G. Indications for liver transplantation (Chapter 41b) In: Liver and Biliary Tract Surgery. Eds. Karaliotas CC, Broelsch CE, Habib NA. Springer, Wien/New York 2006: 531-533.

Beckebaum S, Cicinnati V, Frilling A, Broelsch CE. Liver transplantation. In: Liver: A complete book on hepato-pancreato-biliary diseases. Ed. Mamun-Al-Mahtab. Elsevier, Amsterdam 2009: 535-549.

Beckebaum S, Gerken G, Cicinnati V. Management of patients before and after liver transplantation (Chapter 23). In: Hepatology. A clinical textbook. Eds. Mauss S, Berg T, Rockstroh JK, Sarrazin C, Wedemeyer H. Flying publisher, Düsseldorf 2009:335-374. [Letzte Überarbeitung 2011, Druck 2012]

Beckebaum S, Gerken G, Cicinnati VR. Update in Transplant Hepatology. In: Hepatology – a clinical textbook. Mauss S, Berg T, Rockstroh J, Sarrazin C, Wedemeyer H, et al. eds. Flying Publishers, third edition 2012.

Cicinnati VR, Beckebaum S. Lebertransplantation. In: Harrisons Innere Medizin. Dienstag JL, Chung RT (Autoren Originalausgabe). Dietel M, Suttorp N, Zeitz M (Hrsg. deutschsprachige Ausgabe); Longo DL, Fauci AS, Kasper DL, Hauser SL, Jameson JL, Loscalzo J (Hrsg. Originalausgabe). ABW Wissenschaftsverlag 2012.

Beckebaum S, Cicinnati VR, Radtke A. Transplant Hepatology. In: Hepatology – a clinical textbook. Mauss S, Berg T, Rockstroh J, Sarrazin C, Wedemeyer H, et al. (eds.) Flying Publishers, fourth edition 2013.

Benckert C, Cicinnati V, Beckebaum S. Lebertumoren (Kapitel 43). Interdisziplinäre Viszeralmedizin. Eds. Erckenbrecht JF, Jonas S. 2015.

S. Beckebaum, V. R. Cicinnati. Transplant hepatology: a comprehensive update. In: Hepatology – a clinical textbook. Mauss S, Berg T, Rockstroh J, Sarrazin C, Wedemeyer H, et al. (eds.) Flying Publishers, 9th  edition 2018.